Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Gebski

Showing results (81-90 of 106) with videos related to

Pageof 11
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 5, 2013
Final results of Australasian Gastrointestinal Trials Group ARCTIC study: an audit of raltitrexed for patients with cardiac toxicity induced by fluoropyrimidinesD Ransom, K Wilson, M Fournier, et al.
International Journal of Obesity (2005)|January 11, 2014
Changes in body weight and blood pressure: paradoxical outcome events in overweight and obese subjects with cardiovascular diseaseR V Seimon, D Espinoza, L Ivers, et al.
British Journal of Cancer|July 28, 2012
Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patientsU Wagner, C Marth, R Largillier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 1997
Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: a phase III randomized trial. Australian-New Zealand Breast Cancer Trials GroupM J Byrne, V Gebski, J Forbes, et al.
The British Journal of Surgery|September 10, 2015
Meta-analysis of radical resection rates and margin assessment in pancreatic cancerM D Chandrasegaram, D Goldstein, J Simes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 2012
Health-related quality of life in recurrent platinum-sensitive ovarian cancer--results from the CALYPSO trialM Brundage, M Gropp, F Mefti, et al.
Australian and New Zealand Journal of Medicine|May 26, 1999
Osteolymphoma (primary bone lymphoma): an Australian review of 70 cases. Australasian Radiation Oncology Lymphoma Group (AROLG)D R Christie, M B Barton, G Bryant, et al.
Breast Cancer Research and Treatment|April 28, 2019
Dose intensity in anthracycline-based chemotherapy for metastatic breast cancer: mature results of the randomised clinical trial ANZ 9311Stephen P Ackland, V Gebski, N Zdenkowski, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 1, 2013
Results of a 7-day aprepitant schedule for the prevention of nausea and vomiting in 5-day cisplatin-based germ cell tumor chemotherapyI N Olver, P Grimison, M Chatfield, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2016
Prognostic and predictive effects of primary versus secondary platinum resistance for bevacizumab treatment for platinum-resistant ovarian cancer in the AURELIA trialF Trillsch, S Mahner, F Hilpert, et al.
Pageof 11

Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 5, 2013
Final results of Australasian Gastrointestinal Trials Group ARCTIC study: an audit of raltitrexed for patients with cardiac toxicity induced by fluoropyrimidinesD Ransom, K Wilson, M Fournier, et al.
International Journal of Obesity (2005)|January 11, 2014
Changes in body weight and blood pressure: paradoxical outcome events in overweight and obese subjects with cardiovascular diseaseR V Seimon, D Espinoza, L Ivers, et al.
British Journal of Cancer|July 28, 2012
Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patientsU Wagner, C Marth, R Largillier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 1997
Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: a phase III randomized trial. Australian-New Zealand Breast Cancer Trials GroupM J Byrne, V Gebski, J Forbes, et al.
The British Journal of Surgery|September 10, 2015
Meta-analysis of radical resection rates and margin assessment in pancreatic cancerM D Chandrasegaram, D Goldstein, J Simes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 2012
Health-related quality of life in recurrent platinum-sensitive ovarian cancer--results from the CALYPSO trialM Brundage, M Gropp, F Mefti, et al.
Australian and New Zealand Journal of Medicine|May 26, 1999
Osteolymphoma (primary bone lymphoma): an Australian review of 70 cases. Australasian Radiation Oncology Lymphoma Group (AROLG)D R Christie, M B Barton, G Bryant, et al.
Breast Cancer Research and Treatment|April 28, 2019
Dose intensity in anthracycline-based chemotherapy for metastatic breast cancer: mature results of the randomised clinical trial ANZ 9311Stephen P Ackland, V Gebski, N Zdenkowski, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 1, 2013
Results of a 7-day aprepitant schedule for the prevention of nausea and vomiting in 5-day cisplatin-based germ cell tumor chemotherapyI N Olver, P Grimison, M Chatfield, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2016
Prognostic and predictive effects of primary versus secondary platinum resistance for bevacizumab treatment for platinum-resistant ovarian cancer in the AURELIA trialF Trillsch, S Mahner, F Hilpert, et al.
Pageof 11